Cutler Group’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $47K | Buy |
700
+500
| +250% | +$33.6K | 0.02% | 398 |
|
2023
Q4 | $12K | Sell |
200
-1,800
| -90% | -$108K | ﹤0.01% | 953 |
|
2023
Q3 | $90K | Sell |
2,000
-860
| -30% | -$38.7K | 0.01% | 576 |
|
2023
Q2 | $160K | Buy |
2,860
+2,160
| +309% | +$121K | 0.02% | 383 |
|
2023
Q1 | $31K | Buy |
+700
| New | +$31K | ﹤0.01% | 748 |
|
2022
Q4 | – | Sell |
-12,553
| Closed | -$820K | – | 1849 |
|
2022
Q3 | $820K | Sell |
12,553
-247
| -2% | -$16.1K | 0.06% | 186 |
|
2022
Q2 | $777K | Sell |
12,800
-10,668
| -45% | -$648K | 0.05% | 207 |
|
2022
Q1 | $1.47M | Buy |
23,468
+730
| +3% | +$45.8K | 0.08% | 155 |
|
2021
Q4 | $1.72M | Buy |
22,738
+9,838
| +76% | +$745K | 0.07% | 178 |
|
2021
Q3 | $1.44M | Buy |
12,900
+2,320
| +22% | +$260K | 0.06% | 189 |
|
2021
Q2 | $1.71M | Buy |
10,580
+2,580
| +32% | +$417K | 0.08% | 179 |
|
2021
Q1 | $974K | Sell |
8,000
-4,760
| -37% | -$580K | 0.05% | 277 |
|
2020
Q4 | $1.95M | Buy |
12,760
+12,360
| +3,090% | +$1.89M | 0.09% | 130 |
|
2020
Q3 | $33K | Buy |
+400
| New | +$33K | ﹤0.01% | 1009 |
|
2020
Q2 | – | Sell |
-800
| Closed | -$33K | – | 1641 |
|
2020
Q1 | $33K | Sell |
800
-1,300
| -62% | -$53.6K | ﹤0.01% | 877 |
|
2019
Q4 | $127K | Buy |
+2,100
| New | +$127K | 0.01% | 630 |
|
2019
Q3 | – | Hold |
0
| – | – | – | 1582 |
|
2019
Q2 | – | Hold |
0
| – | – | – | 1670 |
|
2019
Q1 | – | Hold |
0
| – | – | – | 1607 |
|
2018
Q4 | – | Hold |
0
| – | – | – | 1714 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 1709 |
|
2018
Q2 | – | Sell |
-6,097
| Closed | -$278K | – | 1757 |
|
2018
Q1 | $278K | Buy |
+6,097
| New | +$278K | 0.02% | 445 |
|
2017
Q4 | – | Sell |
-600
| Closed | -$10K | – | 2223 |
|
2017
Q3 | $10K | Buy |
600
+263
| +78% | +$4.38K | ﹤0.01% | 1892 |
|
2017
Q2 | $5K | Buy |
+337
| New | +$5K | ﹤0.01% | 2391 |
|